TritonPoint Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$545K Buy
1,294
+28
+2% +$11.2K 0.05% 172
2026
Q2
$458K Sell
1,266
-168
-12% -$57.5K 0.05% 186
2026
Q1
$505K Sell
1,434
-22
-2% -$7.84K 0.05% 172
2025
Q4
$477K Sell
1,456
-448
-24% -$142K 0.05% 180
2025
Q3
$537K Sell
1,904
-30
-2% -$8.7K 0.05% 210
2025
Q2
$540K Buy
1,934
+106
+6% +$30K 0.05% 201
2025
Q1
$569K Buy
1,828
+99
+6% +$29.2K 0.05% 199
2024
Q4
$451K Buy
1,729
+9
+0.5% +$2.67K 0.04% 218
2024
Q3
$555K Buy
1,720
+194
+13% +$63.5K 0.05% 202
2024
Q2
$477K Sell
1,526
-82
-5% -$24.1K 0.05% 207
2024
Q1
$435K Buy
1,608
+63
+4% +$18.4K 0.05% 215
2023
Q4
$445K Buy
+1,545
New +$421K 0.04% 225

Other funds holding AMGN

TritonPoint Wealth's AMGN Position: Q3 2026 in Review

TritonPoint Wealth increased its Amgen (AMGN) stake by 2.2% in Q3 2026, buying an estimated $11.2K and bringing the position to 1,294 shares worth $545K. The position accounts for 0.05% of the portfolio, ranked #172.

TritonPoint Wealth first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $569K in Q1 2025. 3,263 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • TritonPoint Wealth held 1,294 shares of Amgen worth $545K as of Q3 2026.
  • TritonPoint Wealth bought 28 Amgen shares in Q3 2026, an estimated $11.2K.
  • Amgen made up 0.05% of TritonPoint Wealth's portfolio in Q3 2026, its #172 holding.
  • TritonPoint Wealth first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • TritonPoint Wealth's Amgen position peaked at $569K in Q1 2025.
  • 3,263 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on TritonPoint Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.